Anti Arrhythmics

DRUG2 trials

Sponsors

University of Miami, University of Pennsylvania

Conditions

Atrial Fibrillation

Phase 3

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

CompletedNCT04037397

University of PennsylvaniaAtrial Fibrillation

Start: 2019-09-24End: 2024-10-01Updated: 2024-11-12

Phase 4

Liraglutide Effect in Atrial Fibrillation

Active, not recruitingNCT03856632

University of MiamiAtrial Fibrillation

Start: 2019-03-18End: 2026-12-31Updated: 2026-05-01